Search results
Jan 11, 2016 · GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable. On this monthly podcast, Host Kim Thiboldeaux explores topics relating to multi-cancer early ...
- Careers
It’s what makes our company different from any other. We’re...
- Methylation
In 2019, GRAIL announced its proprietary methylation...
- Who We Are
We are a healthcare company, pioneering new technologies to...
- Clinical Studies
We are committed to the utmost scientific rigor and have...
- Manuscripts
Blood-based tests for multicancer early detection...
- External Sponsored Research
GRAIL encourages the submission of scientifically sound and...
- Partnerships
Biopharma Partnerships. Our newly available post-diagnosis...
- Biopharma
GRAIL’s clinical laboratory is certified under the Clinical...
- Our Journey
As a healthcare company with a mission to detect cancer...
- Careers
Grail (styled GRAIL) is an American biotechnology company in Menlo Park, California.It is a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms.
- 2015; 8 years ago
- Biotechnology
- Menlo Park, California, United States
- Subsidiary
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
Sep 21, 2020 · GRAIL was founded by Illumina in 2016 and was spun out as a standalone company, powered by Illumina’s NGS technology, to develop state-of-the-art data science and machine learning and create the atlas of cancer signals in the blood, enabling multi-cancer early detection tests.
Aug 18, 2021 · GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission's ongoing regulatory review. Illumina, the global leader in DNA ...
Dec 21, 2023 · Illumina appeals FTC’s order to divest Grail with plea for cancer screening test By Susan Kelly • June 6, 2023 The DNA-sequencing company that has been fighting regulators over orders to reverse its 2021 acquisition of Grail is accusing the U.S. government of overreach and collusion with European regulators. Read the full article
People also ask
What does Grail do?
Who owns Grail?
Where is Grail headquartered?
What does Grail stand for?
GRAIL and Illumina have a long history. Illumina formed GRAIL and spun it out in 2016. GRAIL's first employees were part of Illumina, which still owns 12 percent of the company. GRAIL and Illumina are not competitors—this is a vertical acquisition. Based on past experience, when Illumina enters a market, the market expands.
